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Abstract: 
A new Supercritical fluid liquid chromatographic (SFC) method has been developed in normal-phase conditions for the 
determination of enantiomeric purity of Montelukast sodium (S,E)-2-(1-((1-3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-
hydroxypropan-2-yl)phenyl)propylthio)ethyl) cyclopropyl) acetic acid (R-isomer) (Anti asthmatic drug) in bulk drugs and in 
dosage forms. The sample was screened on the analytical SFC to determine the best column for the separation. The 
screening conditions are Column: Chiralpak AS-H (250 mm x 4.6 mm, 5 μm) column using a mobile phase system 
containing Supercritical fluid (Co2) and 2-Propanol in the ratio (85:15% v/v). The mobile-phase compositions and the 
differences in separation capability of the method is noted. The resolution between two enantiomers is found to be greater 
than 1.5. The SFC method for the separation of enantiomers of Montelukast is proved Accurate, Precise, Linear and 
robust. Relative standard deviation of retention times and peak areas were better than 0.2% and 0.4%, respectively, for 
precision.  
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Introduction 
Montelukast sodium is primarily used for the treatment of asthma in children and adults. It is a potent selective inhibitor of 
leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor cysLT1. This compound is one of the most significant 
advances in asthma therapy in the last 25 years and is commonly used for the treatment of nocturnal asthma. Literature 
survey reveals that chiral liquid chromatographic method is for the separation of enantiomeric purity for Montelukast 
sodium and its S-enantiomer. The present study illustrates development and validation of a simple, accurate and precise 
procedure for determination of s-enantiomer of montelukast sodium by SFC method in bulk and in tablet dosage form. It 
can be applied for preparative SFC separation method for resolving the enantiomers of Montelukast. Chromatographic 
separations of enantiomers have attracted wide attention since the important difference in biological activity of 
enantiomers became recognized. In this paper SFC was chosen because of solvent saving relative to conventional 
HPLC. 
The objective of the present investigation is to develop and validate a simple, reliable, and Supercritical fluid liquid 
chromatographic method for the enantiomeric separation of Montelukast using an amylose-based CSP column. The 
mobile phase in normal phase mode is simple to prepare and the method is rugged in any environment and comfort in 
use. 
Experimental 
Chemicals and reagents 
 Montelukast racemic mixture (±) was obtained from the R&D department of Inogent laboratories (Hyderabad, India). 
Chemical structure is presented in Figure 1. HPLC-grade 2-Propanol and Methanol were purchased from Merck (Mumbai, 
India). All other chemicals were of analytical-grade, Carbon dioxide with high purity was supplied from MRG Enterprises 
Hyderabad, India. The analyte concentration of Montelukast was fixed as 1.0 mg/mL. Working solutions of Montelukast 
were prepared in Methanol. 
Apparatus 
The SFC experiments were performed on a Thar SD-ASFC-2 system (Thar Technologies, Pittsburgh, PA) equipped with a 
Waters PDA detector. The system was controlled by Superchrom software. The enantiomeric separation was performed 
on a Chiralpak AS-H [Amylose tris (3,5-dimethylphenylcarbamate) coated on 5μm silica-gel), 250 X 4.6 mm i.d., 5 μm]. 
The chromatography was conducted using CO2 composed with different types and percentages of alcohol modifiers as 
the mobile phase. For the separation experiments, the total flow rate of the mobile phase, the outlet backpressure, the 
injection volume, and the UV detection wavelength were fixed as at 2.5 mL/min, 100 bars, 20 μL, and 230 nm, 
respectively. The oven temperature was set at 25°C, to determine the effect of temperature on enantiomeric separation. 
The chromatographic parameters, including the retention factor (k), the separation factor (α), and the resolution (Rs) were 
selected to evaluate the separation of the compounds. All the chromatographic results were repeated three times.  
Different chiral columns were also employed during method development namely Chiralcel OD-H (250 × 4.6 mm,5µ), 
Chiralpak IC (250 × 4.6 mm,5µ),Amylose-2(250 × 4.6 mm,5µ), Chiralcel OJ-H (250 × 4.6 mm,5µ),Chiralpak AS-H (250 × 
4.6 mm,5µ) and finally on Chiralpak AD-H (250 × 4.6 mm,5µ).  
Validation of the method  
Precision  
Precision was determined by measuring repeatability and reproducibility of retention times and peak areas of each 
enantiomer. In order to determine the repeatability of the method, six injections (n = 6) of standard was carried out from 
single preparation. The reproducibility of the method was determined by analyzing six different preparations of test 
solutions containing Montelukast (1.0 mg/mL). 
Linearity 
Linear response was determined by preparing and analyzing five calibration solutions of the enantiomers (concentration 
from 0.5 mg/mL to 2.0 mg/mL) in methanol. Regression curve was obtained by plotting peak area versus concentration 
using the least squares method. Linearity was checked for three consecutive days in the same concentration range from 
the same stock solution. The percentage relative standard deviation of the slope and Y-intercept of the calibration curve 
were calculated. 
Robustness  
The robustness of a method is the ability of the method to remain unaffected by small changes in parameters such as 
flow rate, mobile phase composition, and column temperature. To determine robustness of the method experimental 
conditions were purposely altered and chromatographic resolution between (+) enantiomer and (-) enantiomer was 
evaluated. The flow rate of the mobile phase was 2.50 mL/min. To study the effect of flow rate on the resolution of 
enantiomers, 0.5 units (±20%) changed it from 2.0 to 3.0 mL/min. The effects of change in percent of Supercrit ical fluid 
Carbon dioxide, and 2-Propanol on resolution were studied by varying from CO2 to +2% while the other mobile phase 
components were held constant as stated in the Apparatus section. 
ISSN 2321-807X 
520 | P a g e                                                       O c t o b e r  1 5 ,  2 0 1 3  
Results and Discussion 
Optimization of chromatographic conditions 
Racemic mixture solution of Montelukast (10 μg/mL each) is prepared in methanol for development. To develop a rugged 
and suitable SFC method for the separation of the two enantiomers, different stationary phases and mobile phases were 
employed. Initial screening of chiral column was carried out by several chiral LC column suppliers. Various chiral 
columns, namely Chiralcel OD-H (250 × 4.6 mm,5µ), Chiralpak IC (250 × 4.6 mm,5µ),Amylose-2(250 × 4.6 mm,5µ), 
Chiralcel OJ-H (250 × 4.6 mm,5µ),Chiralpak AS-H (250 × 4.6 mm,5µ),were employed. All these columns failed to provide 
selectivity between Montelukast peak and the undesired enantiomer peak using different possible mobile phases. 
Different method development trails are shown in Figure .Different method development trail conditions are tabulated in 
Table.1. 
It was continued to select the best stationary and mobile phases that would give optimum resolution and selectivity for the 
two enantiomers. There was an indication of separation on Chiralpak AS-H (250 × 4.6 mm, 5 μm) column using a mobile 
phase consisting of Supercritical fluid liquid (Co2), and 2-Propanol in the ratio 85:15. The composition of the mobile phase 
was optimized to enhance the chromatographic efficiency and resolution between the enantiomers. Based on the data 
obtained from method development and optimization activities, Chiralpak AS-H (250 × 4.6 mm, 5 μm) column with mobile 
phase of Supercritical fluid liquid (Co2) and 2-Propanol (85:15%,v/v) was selected for the final method. The flow rate of 
the final method was 2.5 mL/min with an injection volume of    20 μL. The column temperature was 25°C, and the 
detection wavelength was 230 nm. Under these conditions, the two enantiomers were separated well and the peak of (S)-
enantiomer eluted after the peak of Montelukast. In the optimized method, the typical retention times of Montelukast and 
(s)-enantiomer were approximately Montelukast a total run time of 20 min. The separation of an approximately 1:1 (wt/wt) 
mixture solution (in methanol) of the two enantiomers is shown in Figure . An amylose based chiral stationary phase 
contained five chiral centers per unit, and Montelukast had only one chiral center close to the thiopropyl methyl 
cyclopropane group in the structure. The stereoelectronic interactions between the enantiomers and the chiral stationary 
phase generated enantioselectivity, thus causing significant differences in the migration of the enantiomers inside the 
column. Having the right amount of methanol in the mobile phase also played an important role in affecting the steric 
environment of the chiral cavities or channels of the stationary phase and contribute to enantioselectivity. However, an 
excessive amount of methanol was likely to cut down the resolution by taking up chiral centers of the chiral stationary 
phase or forming hydrogen bondings with the enantiomers instead of the hydrogen bondings between the enantiomers 
and the stationary phase (14). Other important interactions between the enantiomers and the stationary phase such as 
π¨Cπ bonding, Vander Waals forces, dipole induced dipole attractions, and steric effects can also achieve better 
resolution on Chiralpak AS-H column.  
Validation of method 
In the repeatability study, the relative standard deviation (RSD) was better than 0.2% for the retention times and 0.4% for 
peak areas of both the enantiomers. In reproducibility studies, results show that RSD values were in the same order of 
magnitude than those obtained for repeatability. Coefficient of correlation between concentration and detector response 
[0.999 for the first eluting (+) enantiomer and 0.999 for the second eluting (¨C) enantiomer] shows that method is linear 
over the concentration range of 0.4¨C1.2 mg/mL.  The limit of detection (LOD), determined as the amount for which the 
signal to- noise ratio was ~3:1 for both enantiomers of Montelukast, was 0.05 mg/mL. 
The chromatographic resolution of Montelukast peaks were used to evaluate the method robustness under modified 
conditions. The resolution between (+) enantiomer and (-) enantiomer was greater than 2.0 under all separation 
conditions tested, demonstrating sufficient robustness. 
 
Conclusions 
A simple, rapid, accurate and precise Supercritical fluid liquid chromatographic method for the enantiomeric separation of 
Montelukast has been developed and validated. Amylose based Chiralpak AS-H column was found to be suitable for the 
separation of the enantiomers of Montelukast. Use of Chiralpak AS-H column with Supercritical fluid liquid (CO2) and 2-
Propanol (85:15%, v/v) as mobile phase was most suitable for separation of the enantiomers of Montelukast. The analysis 
of enantiomeric separations by SFC is less time, cost effective and environmentally eco friendly than Normal phase liquid 
chromatographic Methods. This method is used for the isolation of un required isomer by using the preparative SFC 
system with less time and less cost.  
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Figure 1: Montelukast R isomer and S-Isomer 
Chromatograms: 
a) Montelukast spiked with S-isomer: 
 
 
 
b) Montelukast s-Isomer: 
 
ISSN 2321-807X 
522 | P a g e                                                       O c t o b e r  1 5 ,  2 0 1 3  
c) Montelukast sample: 
 
 
Table I. Different method development trail conditions 
 
S.No 
 
Column  name 
 
Total flow(g/min) 
 
% of Co solvent 
 
Remarks 
 
1 
 
Chiralcel OD-H 
 
2 
 
15% Methanol 
 
No separation of 
enantiomer 
2  
Chiralpak IC 
 
2 
 
15%(Methanol+ ACN) 
 
Poor peak shapes  
3  
Amylose -2 
 
2 
 
15% Methanol 
 
Poor resolution 
4  
Chiralcel OJ-H 
 
2 
 
20%(0.5% TFA in ACN) 
 
Poor resolution 
5  
Chiralpak AS-H 
 
2 
 
15% 2-Propanol 
 
Separation is good 
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Different Method development chromatograms for Montelukast: 
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Table .II  Repeatability and intermediate precision results of the developed Chiral SFC Method 
 
                   Parameter                                                               Results 
Repeatability (n=6,%RSD)                                                          0.21 
 Retention time (R-enantiomer)                                                   0.33  
 Retention time (S-enantiomer)                                                   0.36 
Area (R-enantiomer)                                                                   0.85 
Area (S-enantiomer)                                                                   1.08 
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